Anti-Human Immunodeficiency Virus Interactions of SCH-C (SCH 351125), a CCR5 Antagonist, with Other Antiretroviral Agents In Vitro

Benzer Materyaller

• TAK-220, a Novel Small-Molecule CCR5 Antagonist, Has Favorable Anti-Human Immunodeficiency Virus Interactions with Other Antiretrovirals In Vitro
  Yazar:: Tremblay, Cécile L., ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• Analysis of the Mechanism by Which the Small-Molecule CCR5 Antagonists SCH-351125 and SCH-350581 Inhibit Human Immunodeficiency Virus Type 1 Entry
  Yazar:: Tsamis, Fotini, ve diğerleri
  Baskı/Yayın Bilgisi: (2003)
• Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1
  Yazar:: Strizki, Julie M., ve diğerleri
  Baskı/Yayın Bilgisi: (2005)
• SCH-C (SCH 351125), an orally bioavailable, small molecule antagonist of the chemokine receptor CCR5, is a potent inhibitor of HIV-1 infection in vitro and in vivo
  Yazar:: Strizki, Julie M., ve diğerleri
  Baskı/Yayın Bilgisi: (2001)
• Pharmacokinetics and Pharmacodynamics of TBR-652, a Novel CCR5 Antagonist, in HIV-1-Infected, Antiretroviral Treatment-Experienced, CCR5 Antagonist-Naïve Patients
  Yazar:: Marier, Jean-Francois, ve diğerleri
  Baskı/Yayın Bilgisi: (2011)